- Preamble [SYSTEM]
- Fund & Investor Interest
- Street Moves
- Solebury Trout Updates
- Market Commentary
- IPO News
- Expert Interactions
- Banker Comments & Notes
- Conference Snippet
- Industry Snippets
- Social Media
- Solebury Trout Talks

Industry Snippets: EndpointNews - The pandemic IPOs keep rolling, as Generation, Avidity, Vaxcyte each claim 200M+
Endpoints News
If it wasn’t already, biotech’s pandemic IPO boom is in full swing.
After a week that saw the largest Chinese biotech IPO in history and another $154 million for a company that emerged only last September, four different biotechs raised over $200 million. Each of them upsized their offerings or priced at the top end — or more — of their original range.
Collectively, they raised $926 million, or an average of $231 million per company.